Trialbee Risk Report
Generated on July 17, 2025
1
Risks
Summary
📜 innovation & r&d
Trialbee has undergone significant innovations in recent years, enhancing its capabilities in patient recruitment and engagement for clinical trials. These advancements help facilitate greater participation and diversity in clinical research. The addition of new features to their Honey™ platform and strategic partnerships illustrates their commitment to maintaining a cutting-edge position in the industry.
- Trialbee released new features for the Honey™ platform 🗓 May 17, 2023.
- Trialbee launched an omnichannel connector for the Honey™ platform 🗓 December 6, 2023, to enhance transparency and support patient recruitment.
- A partnership between Trialbee and Belong.Life was announced 🗓 August 8, 2024, to boost clinical trial awareness and enrollment.
- Trialbee joined forces with Massive Bio 🗓 January 31, 2024, to improve trial access and patient recruitment in oncology and hematology.
- Trialbee and Clinerion partnered 🗓 August 26, 2020, for expanded access to global real-world data (RWD).
News & Media
Stay informed with real-time news signals across financial, legal, and operational domains.
Profile
Specialties
DCT, Data Analytics, Decentralized Clinical Trials, Decentralized Trials, Digital Health, Electronic Data Collection, Investigator Recruitment, Patient Engagement, Patient Enrollment, Patient Recruitment, Patient Retention, RWD, RWE, Study Retention, Virtual Trials, clinicaltrials, patientcentricity, patientvoice, realworlddata, realworldevidence